PHILADELPHIA, June 13, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Charles River Laboratories Intl. (NYSE:CRL) ("Charles River") on behalf of the company's long-term shareholders.
Recently a securities fraud complaint was filed against Charles River on behalf of certain investors who purchased shares of the company's stock between May 7, 2020 and March 15, 2023. According to the complaint, during that time period Charles River and certain of the company's senior executives made a series of materially false and/or misleading statements about the company's procurement of non-human primates ("NHPs"), and in particular, long-tailed macaques, from inherently suspicious suppliers.
The complaint further details how, through a series of partial disclosures, investors slowly learned the truth about the company's prior misrepresentations and suffered economic damages as a result therefrom. For example, on February 22, 2023, Charles River disclosed that it had received a subpoena from the U.S. Department of ...
CRL) and Encourages Long-Term CRL Shareholders to Contact the Firm>Full story available on Benzinga.com